Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01652326 · ClinicalTrials.gov registry record
Clinical Quality Improvement of Benzodiazepine-Resistant Alcohol Withdrawal Syndrome
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 792
- Enrollment target
NCT01652326 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 792 participants.
The verdict
NCT01652326 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 792 participants
- Enrollment target
Study Summary
The overarching goal of this project is to improve the clinical quality of patients with Benzodiazepine-resistant alcohol withdrawal syndrome.
Interventions
- DRUG Diazepam
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 792 participants |
| Start Date | 2012-07 |
| Est. Completion | 2015-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01652326
The ClinicalTrials.gov registry entry for NCT01652326 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 792 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Diazepam is the first listed.
NCT01652326 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01652326 about?
NCT01652326 is a clinical study titled "Clinical Quality Improvement of Benzodiazepine-Resistant Alcohol Withdrawal Syndrome". The overarching goal of this project is to improve the clinical quality of patients with Benzodiazepine-resistant alcohol withdrawal syndrome.
What is the current status of trial NCT01652326?
This trial is currently completed. The enrollment target is 792 participants. The study started on 2012-07. Estimated completion is 2015-09.
What interventions are being tested in trial NCT01652326?
The interventions under investigation include: Diazepam (DRUG).
Who is sponsoring clinical trial NCT01652326?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.